Boston NAION Lawyer
Boston NAION Lawyer for Ozempic, Wegovy and GLP-1 Vision Loss Claims
If you developed sudden vision loss or were diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) after taking Ozempic, Wegovy or another GLP-1 medication, you may have grounds to investigate a pharmaceutical injury claim. NAION affects the optic nerve and can cause lasting visual impairment. The FDA now requires GLP-1 drugmakers to warn about a potential increased risk of this rare condition.
Rightful Legal, P.C. helps people in Boston and throughout Massachusetts evaluate serious injuries involving prescription medications. Attorney Tracy Paulsen can review your diagnosis, treatment timeline and available records to assess whether further investigation is warranted. A medication history and NAION diagnosis do not, by themselves, prove that a drug caused an injury or that a manufacturer is legally liable.
Call or text Tracy Paulsen at 617-821-5856 to request a case review.
What Is NAION?
Non-arteritic anterior ischemic optic neuropathy is an injury to the optic nerve associated with reduced blood flow to its front portion. It often develops suddenly and without pain, usually in one eye. Some patients notice a change when they wake up; others discover a dark or missing area in their field of vision.
- Sudden, painless loss of vision or blurred sight in one eye
- Blind spots, missing peripheral vision or reduced central sharpness
- Changes in color perception or difficulty reading and driving
- Visual limitations that may remain permanent
Sudden vision loss requires urgent medical evaluation. Other causes of vision loss can also be emergencies, and a person should not try to diagnose NAION on their own. If symptoms arise, seek prompt medical care and speak with the prescribing clinician about any GLP-1 medication. Do not independently change a prescription.
Are Ozempic and Other GLP-1 Drugs Linked to NAION?
Research and safety reviews have identified a possible association between GLP-1 receptor agonists and NAION. Semaglutide, found in Ozempic, Wegovy and Rybelsus, has been a particular focus of medical research. Other GLP-1 medications include liraglutide and dulaglutide products; tirzepatide medications are also discussed in the broader GLP-1-related safety context.
On November 9, 2026, the U.S. Food and Drug Administration announced that GLP-1 receptor agonist manufacturers must add warnings about a potential increased NAION risk. Its pooled review of 126 clinical trials reported approximately 6.4 cases per 100,000 person-years among GLP-1 users versus 3.8 among comparators. These figures describe population-level observations, not the probability that any particular patient’s vision loss was caused by a medication.
For a more detailed discussion of the diagnosis and statewide claim considerations, read Rightful Legal’s Massachusetts GLP-1 vision loss and NAION lawsuit guide.
When Could a Boston NAION Diagnosis Support a Lawsuit?
A possible case requires more than taking a drug before an eye injury. A lawyer must evaluate which medication was used, whether NAION was accurately diagnosed, the timing of exposure and symptoms, other possible causes, what the manufacturer knew about risks, the warnings in effect at the relevant time and the law governing the claim.
A manufacturer may face claims involving allegedly inadequate warnings or other product-related defects when supported by the facts and law. The FDA’s new warning does not automatically establish that earlier labels were unlawful, that every GLP-1 medication presents the same risk, or that a particular injury was drug-related. Individual causation often requires qualified medical and scientific analysis.
What If I Have Diabetes, Sleep Apnea or High Blood Pressure?
Those conditions can independently increase NAION risk. They do not automatically prevent someone from seeking a case review, but they make a careful assessment of causation especially important. Your attorney may need to compare ophthalmology findings, prescribing records and preexisting conditions with the relevant research. A responsible evaluation should discuss unfavorable facts as well as supportive ones.
Which GLP-1 Vision Loss Cases Are in Federal Litigation?
Federal NAION lawsuits involving certain GLP-1 medications have been centralized in multidistrict litigation, MDL No. 3163, in the U.S. District Court for the Eastern District of Pennsylvania. Plaintiffs allege injuries associated with products including Ozempic, Wegovy, Saxenda and Trulicity. The coordinated proceeding addresses shared discovery and pretrial issues; it is not itself a finding that manufacturers caused NAION or violated the law.
The NAION MDL is separate from MDL No. 3094, which concerns other alleged GLP-1 injuries, including gastrointestinal harm. Not every person with a potential claim is automatically part of an MDL, and applicable filing procedures require case-specific review.
You can explore related claims in Rightful Legal’s Ozempic vision loss lawsuit overview and its Massachusetts Ozempic lawsuit page.
What Evidence Is Important in an Ozempic or GLP-1 NAION Claim?
The strongest starting point is a medically supported timeline. Prescription records may establish medication use, while eye-care records help establish whether the diagnosis was NAION, when the injury appeared and how severe it became.
- Pharmacy records showing the product, dosage, prescribing dates and refill history
- Ophthalmology or neuro-ophthalmology notes, optic nerve imaging and visual-field tests
- Eye examinations completed before symptoms, including routine optometry records
- Medical records concerning diabetes, blood pressure, sleep apnea and other risk factors
- Documentation of missed work, rehabilitation needs, transportation costs and daily limitations
An Often-Overlooked Detail: Your Earlier Eye Examinations
A routine eye examination from before the injury may be as helpful as a record created after the NAION diagnosis. It may establish baseline vision and make changes more understandable. If you used more than one pharmacy or changed clinicians, list each source rather than assuming records cannot be recovered. Write down the date you first noticed symptoms, not just the later date of diagnosis.
What Compensation Could Be Available?
If the legal requirements for liability and causation are met, damages may include past and future medical care, lost income or reduced earning capacity, pain and suffering, and expenses connected with lasting disability. NAION may also affect independence: some people cannot drive safely, perform visually demanding jobs or navigate daily activities as they once did.
There is no reliable standard NAION settlement amount. Compensation depends on the actual evidence, legal issues and the consequences of the injury. No attorney can promise a particular result.
How Long Do I Have to File in Massachusetts?
Massachusetts generally has a three-year statute of limitations for many personal injury tort claims under Massachusetts General Laws Chapter 260, Section 2A. Pharmaceutical claims may raise fact-sensitive questions about when a claim accrued, discovery of injury and causation, federal proceedings and which jurisdiction’s law applies. The FDA announcement does not automatically restart anyone’s deadline.
Speak with an attorney promptly rather than calculating a deadline from the diagnosis date alone. Records, pharmacy histories and witness information may become harder to obtain with time.
What Should You Do After a NAION Diagnosis?
- Obtain urgent eye care for new vision changes and follow medical follow-up instructions.
- Discuss medication risks and continued treatment with the prescribing clinician.
- Request copies of eye-care records, prior vision tests and prescription histories.
- Document functional changes in work, reading, driving and household activities.
- Ask for a legal evaluation before potentially important filing deadlines expire.
You do not have to understand complex drug research to ask whether a case is worth reviewing. You do need to give your attorney and medical team an accurate history, including other health conditions and medications.
Why Choose Tracy Paulsen and Rightful Legal?
Tracy Paulsen founded Rightful Legal, P.C. to provide personal representation for people harmed by negligence and dangerous products. A Massachusetts attorney since 2009, she earned her J.D. from Suffolk University Law School and studied Environmental Science and Anthropology at the University of Virginia. Her Jurisprudence Award for Environmental Law reflects an academic background relevant to claims where science, medical evidence and corporate accountability intersect.
Tracy has experience with matters involving insurers and large corporate interests. At this small, client-focused firm, clients work directly with their lawyer rather than relying on a case manager as the principal contact. The focus is on careful preparation, clear communication and pursuing fair compensation when the facts and law support a claim, including readiness for litigation where appropriate.
Rightful Legal is based in Attleboro and serves clients across Massachusetts, including Boston. The firm does not need a physical Boston office to discuss a potential drug injury claim with a Boston resident.
Frequently Asked Questions About Boston NAION Lawsuits
Possibly. A diagnosis following Ozempic use is a reason to investigate, not automatic proof of causation or liability. Medical records, exposure timing, competing risk factors and legal standards all matter.
Wegovy contains semaglutide. Regulatory reviews have identified a potential NAION risk, and NAION may produce permanent vision impairment. An individual diagnosis must still be evaluated medically.
Partial or visual-field loss can still affect work and independent living. Whether it supports a legal claim depends on causation, injury and the applicable law.
No. An MDL coordinates shared pretrial matters in multiple lawsuits; individuals do not automatically receive compensation simply because the litigation exists.
Not automatically. Diabetes is one recognized NAION risk factor and makes medical causation analysis important.
It may still be worth evaluating. The dates of drug use, first symptoms and medical diagnosis need to be considered together.
Call or text Rightful Legal founder Tracy Paulsen at 617-821-5856. Have your medication names, approximate dates and eye-care providers available if possible.
Talk With a Boston NAION Lawyer About Your Options
Vision loss can disrupt work, family responsibilities and everyday independence. If you were diagnosed with NAION after taking Ozempic, Wegovy or another GLP-1 medication, Rightful Legal can discuss the records that matter and whether your circumstances warrant a legal investigation.
Call or text Attorney Tracy Paulsen at 617-821-5856 to request a consultation.
You can also contact Rightful Legal online.


